Digital and Pharma 4.0

Latest content

AdobeStock_1846816907

Audit-ready by design: why quality documentation is becoming a strategic asset in advanced therapy manufacturing

2026-11-18T09:15:00+00:00

Mike King at IQVIA reveals why digital quality documentation is deemed a key enabler in advanced therapy sectors, increasingly influencing how sponsors select manufacturers.

Join now

Unlock exclusive industry insights

  • Bookmark articles and resources to access anytime
  • Enjoy free access to industry leading resources, webinars and insights
  • Stay informed with the latest news and breakthroughs in drug discovery
  • Receive updates and recommendations tailored to your research interests
Become a member

AdobeStock_2122255560

Anthropic acquires biotech startup exploring AI-led drug development

2026-10-30T11:01:00+00:00

Anthropic has acquired Mithril Medicine, a biotech startup that used its Claude AI models to coordinate an experimental drug development programme for muscular dystrophy.

Patient Enrollment Data On Dual Screens

Rethinking how investigator oversight is evidenced in clinical trials

2026-10-23T09:00:00+01:00

As clinical trials grow more complex, evidence of principal investigator oversight requires a more modern, risk-proportionate approach to demonstrate application of clinical and scientific judgment for areas of highest concern in patient safety and data integrity.

top-down-view-technician-3D-printing-machine

European Pharmacopoeia launches working party for 3D-printed medicines

2026-10-13T11:20:00+01:00

The new group will develop pharmacopoeial quality standards for 3D-printed medicinal products, reflecting the technology’s growing role in personalised medicine manufacturing.

AdobeStock_2095126684

How AI could make formulation development more predictive

2026-10-13T10:17:00+01:00 and

Reflections from a recent panel discussion helped to clarify the most valuable application of artificial intelligence to streamline formulation development.